Cardiovascular drugs Flashcards

(259 cards)

1
Q

What are the type of drugs acting on CVS?

A

anti-hypertensive
cardiotonic drugs
antiarrhythmic drugs
antianginal agents
lipid lowering agents
drugs affecting blood coagulation
drugs used to treat anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hypertension with no known underlying cause

A

essential hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

drugs that work by altering the normal reflexes that control blood pressure aimed at maintaining the blood pressure within normal limits to prevent the damage that hypertension can cause

A

anti-hypertensive drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

subclasses of anti-hypertensive drugs

A

angiotensin-converting enzyme (ACE) inhibitors
angiotensin II receptor blockers (ARBs)
calcium-channel blockers
vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

act in the lungs to prevent ACE from converting angiotensin I to angiotensin II, a powerful vasoconstrictor and stimulator
of aldosterone release

A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

action leads to a decrease in BP an in
aldosterone secretion, with a resultant of?

A

slight increase in serum potassium and loss of serum sodium and fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drugs Under ACE inhibitors?

A
  • Benazepril (Lotensin)
  • Captopril (Capoten)
  • Enalapril (Vasotec)
  • Enalaprilat (Vasotec IV)
  • Fosinopril (Monopril)
    *Lisinopril (Prinivil, Zestril)
  • Moexipril (Univasc)
  • Perindopril (Aceon)
  • Quinapril (Accupril)
  • Ramipril (Altace)
  • Trandolapril (Mavik)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

for the treatment of heart failure and left ventricular dysfunction, ACE inhibitors can be taken with?

A

digoxin and diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraindication for ACE inhibitors?

A

Allergy
Impaired Renal Function
Pregnancy
Lactation
Heart Failure
Salt/volume depletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

selectively bind with the angiotensin II receptors in vascular smooth
muscle and in the adrenal cortex to block vasoconstriction and the release of
aldosterone

A

Angiotensin II Receptor Blockers (ARBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs under ARBs

A
  • Azilsartan (Edarbi)
  • Candesartan (Atacand)
  • Eprosartan (Teveten)
  • Irbesartan (Avapro)
  • Losartan (Cozaar)
  • Olmesartan (Benicar)
  • Telmisartan (Micardis)
  • Valsartan (Diovan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

These drugs are indicated to be used alone or in combination therapy for
the treatment of hypertension and for the treatment of heart failure in
patients who are intolerant to ACE inhibitors.

A

ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

They also slow the progression
of renal disease in patients with hypertension and type 2 diabetes

A

ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ARBs are well
absorbed and undergo metabolism in the liver by
the?

A

cytochrome P450 system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ARBs cross the placenta and are excreted via?

A

urine and feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARBs contraindication?

A

Allergy
PRegnancy
Lactation
Presence of hepatic or renal dysfunction
Hypovolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The risk of decreased serum levels and loss of effectiveness
increases if the ARB is taken in combination with?

A

phenobarbital,
indomethacin, or rifamycin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

There may be a decrease in anticipated antihypertensive effects if
the ARBs is combined with

A

ketoconazole, fluconazole, or diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ARBs should not be used with ___ because of the potential for serious adverse effects

A

ACE inhibitors or renin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

These drugs inhibit the movement of calcium ions
across the membranes of myocardial and arterial muscle cells,
altering the action potential and blocking muscle cell contraction.

A

calcium-channel inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drugs under calcium-channel blockers

A
  • Amlodipine (Norvasc)
  • Felodipine (Plendil)
  • Isradipine (DynaCirc, DynaCirc CR)
  • Nicardipine (Cardene, Cardene SR)
  • Diltiazem (Cardizem, Dilacor CR)
  • Nifedipine (Procardia XL)
  • Nisoldipine (Sular)
  • Verapamil (Calan SR)
  • Clevidipine (Cleviprex)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Calcium-channel blockers are also sometimes
used in the treatment of?

A

Raynaud’s disease and migraine headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

These calcium channel blockers are available in IV form for short-term
use when oral administration is not feasible

A

Nicardipine
Clevidipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Contraindications of calcium-channel blockers

A

Allergy
Heart block or sick sinus syndrome
Renal or hepatic dysfunction
Pregnancy
Lactation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
diltiazem calcium-channel blocker should not be taken with --- cause it potentially serious effect to note which is an increase in serum levels and toxicity
cyclosporine
26
These anti-hypertensive drug act directly on vascular smooth muscle to cause muscle relaxation, leading to vasodilation and drop in BP.
vasodilators
27
Example of vasodilators
Diazoxide (Hyperstat) * Hydralazine (Apresoline) * Minoxidil (Loniten) * Nitroprusside (Nitropress)
28
vasodilators that are used intravenously
Diazoxide and nitroprusside
29
vasodilator that is available for oral and intramuscular
hydralazine
30
contraindication of vasodilators
Allergy Pregnancy Lactation Peripheral vascular disease, CAD, heart failure, tachycardia Functional hypoglycemia
31
Hydralazine can produce additive hypotensive effects when given with
adrenergic or other anti-hypertensive drugs
32
medications used to treat hypertension
anti-hypertensive drugs
33
specific receptors found in blood vessels and in the adrenal gland that react with angiotensin II to cause vasoconstriction and release of aldosterone.
angiotensin II receptors
34
common, often asymptomatic disorder in which systolic blood pressure persistently exceeds 140 mm Hg and/or diastolic pressure exceeds 90 mm Hg
hypertension
35
sustained blood pressure that is lower than that required to adequately perfuse all of the body’s tissues
hypotension
36
force that resists the flow of blood through the vessels, mostly determined by the arterioles, which contract to increase resistance; important in determining overall blood pressure
peripheral resistance
37
are drugs used to increase the contractility of the heart muscle for patients experiencing heart failure
cardiotonic agents
38
subclasses of cardiotonic agents
cardiac glycoside phosphodiesterase inhibitors
39
The cardiac glycosides were originally derived from the
foxglove or digitalis plant
40
e foxglove or digitalis plant were once ground up to make
digitalis leaf
41
a cardiotonic drug subclass which is indicated for treating heart failure and irregular heartbeats
cardiac glycosides
42
drugs under cardiac glycoside
digoxin digitoxin
43
it has a brand name called Lanoxin.
digoxin
44
digoxin is most frequently it is used for
atrial fibrillation, atrial flutter, and heart failure
45
is a cardiac glycoside used for the treatment of heart failure and certain kinds of heart arrhythmia
digitoxin
46
It is a phytosteroid and is similar in structure and effects to digoxin.
digitoxin
47
cardiac glycosides has a rapid onset of action and rapid absorption of ___ when taken orally, and ___ minutes when given intravenously
30-120, 5-30
48
There is a risk of increased therapeutic effects and toxic effects of cardiac glycosides if it is taken with
verapamil, amiodarone, quinidine, quinine, erythromycin, tetracycline, or cyclosporine
49
Cardiac glycosides drugs may be less effective if it is combined with
thyroid hormones, metoclopramide, or penicillamine
50
Absorption of oral cardiac glycosides may be decreased if it is taken with
cholestyramine, charcoal, colestipol, antacids, bleomycin, cyclophosphamide, or methotrexate
51
This belongs to a second class of drugs that act as cardiotonic (inotropic) agents
phosphodiesterase inhibitors
52
phosphodiesterase inhibitors include
inamrinone (Inocor) and milrinone (Primacor)
53
Approved only for use in patients with HF who does not have been responsive to digoxin, diuretics, or vasodilators
phosphodiesterase inhibitors
54
phospodiesterase inhibitors that are used intravenously
Inamrinone and milrinone
55
enlargement of the heart, commonly seen with chronic hypertension, valvular disease, and heart failure
cardiomegaly
56
a disease of the heart muscle that leads to an enlarged heart and eventually to complete heart muscle failure and death
cardiomyopathy
57
discomfort with respirations, often with a feeling of anxiety and inability to breathe, seen with left-sided heart failure.
dyspnea
58
a condition in which the heart muscle fails to adequately pump blood around the cardiovascular system, leading to a backup or congestion of blood in the system
heart failure
59
blood-tinged sputum, seen in left-sided heart failure when blood backs up into the lungs and fluid leaks out into the lung tissue
hemoptysis
60
getting up to void at night, reflecting increased renal perfusion with fluid shifts in the supine position when person has gravity-dependent edema related to heart failure; other medical conditions, including urinary tract infection, increase the need to get up and void
nocturia
61
difficulty breathing when lying down, often referred to by the number of pillows required to allow a person to breath comfortably
orthopnea
62
effect resulting in an increased force of contraction
positive inotropic
63
severe left-sided heart failure with backup of blood into the lungs, leading to loss of fluid into the lung tissue
pulmonary edema
64
rapid and shallow respirations, seen with left sided heart failure
tachypnea
65
also known as cardiac dysrhythmia medications, are a group of pharmaceuticals that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation
antiarrhythmic agents
66
classes of antiarrhythmic agents
class 1,2,3,4
67
antiarrhythmics that are fast sodium channel blockers
class 1
68
class 1a antiarrhythmic drugs
Disopyramide (Norpace) Procainamide (Pronestyl) quinidine (Generic)
69
class 1b antiarrhythmics
lidocaine (Xylocaine) mexiletine (Mexitil)
70
class 1c antiarrhythmics
Flecainide (Tambocor) Propafenone (Ryhtmol)
71
antiarrhythmic drugs preferable in conditions such as tachycardia, in which the sodium gates are open frequently
class 1a
72
Also for the treatment of potentially life-threatening ventricular arrhythmias and should not be used to treat other arrhythmias because of the risk of a proarrhythmic effect
class 1a antiarrhythmic drugs
73
class 1a antiarrhythmic drugs should not be used to treat other arrhythmias because of the risk of
proarrhythmic effect
74
class 1 antiarrhythmic available in oral form
Disopyramid, Flecainide, and propafenone
75
class 1a available in intramuscular (IM), intravenous (IV), and oral forms
Procainamide and Quinidine
76
class 1b antiarrythmic that is administered by the IM or IV route, and can also be given as a bolus injection in emergencies when monitoring is not available to document the exact arrhythmia
Lidocaine
77
class 1b antiarrhythmics that is an oral drug administered to adults only
Mexiletine
78
antiarrhythmics that are conventional beta blockers
class 2
79
Drug under Class II Antiarrhythmics
● Acebutolol ● Esmolol ● Propranolol
80
these drugs competitively block beta-receptor sites in the heart and kidneys
class 2 antiarrythmics
81
class 2 antiarrhythmics are indicated for the treatment of
supraventricular tachycardias and PVCs
82
Acebutolol is administered
orally
83
Esmolol is administered
intravenously
84
Propranolol is administered
orally or intravenously
85
The use of class 2 antiarrhythmic drugs is contraindicated in the presence of
sinus bradycardia (rate less than 45 beats/min) AV block cardiogenic shock HF asthma respiratory depression diabetes thyroid dysfunction
86
these drugs act by blocking depolarizing currents and thereby prolonging the effective refractory period of the myocardium.
class 3 antiarrhythmics
87
drugs under class 3 antiarrhythmics
● Amiodarone ● Dofetilide ● Ibutilide ● sotalol
88
these drugs block potassium channels and slow the outward movement of potassium during phase 3 of the action potential, prolonging it. All of these drugs are proarrhythmic and have the potential of inducing arrhythmias
class 3 antiarrhythmics
89
class 3 antiarrhythmic drug that is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy
Amiodarone HCl injection
90
Amiodarone is available in
an oral or intravenous form
91
Dofetilide and sotalol are administered only in
oral form
92
Ibutilide is given
IV
93
antiarrhythmic drugs that are slow non-dihydropyridine calcium channel blockers
class 4 antiarrhythmics
94
Drug under Class IV Antiarrhythmics
● Diltiazem ● Verapamil
95
these antiarrhythmic drugs block the movement of calcium ions across the cell membrane, depressing the generation of action potentials and delaying phases 1and 2 of repolarization, which slows automaticity and conduction.
class 4 antiarrhythmics
96
diltiazem and verapamil are used as
antihypertensives and to treat angina
97
● Diltiazem is administered .
intravenously
98
When used as an antiarrhythmic, verapamil is used
intravenously
99
drugs that affect the action potential of cardiac cells and are used to treat arrhythmias and restore normal rate and rhythm
antiarrhythmics
100
slower-than-normal heart rate (usually less than60 beats/min)
bradycardia
101
the amount of blood the heart can pump per beat; influenced by the coordination of cardiac muscle contraction, heart rate, and blood return to the heart
cardiac output
102
large research study run by the National Heart and Lung Institute that found that long-term treatment of arrhythmias may havea questionable effect on mortality, and in some cases actually lead to increased cardiac death; basis for the current indication for antiarrhythmics (short-term use to treat life-threatening ventricular arrhythmias).
Cardiac Arrhythmia Suppression Test (CAST)
103
-blocks to conduction of an impulse through the cardiac conduction system; can occur at the atrioventricular node, interrupting conduction from the atria into the ventricles, or in the bundle branches within the ventricles,preventing the normal conduction of the impulse.
heart blocks
104
the study of the forces moving blood throughout the cardiovascular
hemodynamics
105
drugs are used to reduce ischemia by increasing the delivery of oxygen-rich blood to cardiac tissues or by reducing oxygen consumption by the coronary vessels. Either of these mechanisms can reduce ischemia and lead to a decrease in anginal pain.
antianginal agents
106
antianginal agents subclasses
nitrites and nitrates beta blockers calcium channel blockers
107
antianginals that work mainly by decreasing venous return to the heart (preload) and decreasing systemic vascular resistance (afterload)
nitrites and nitrates
108
are the rapid- and long-acting nitrates available for clinical use
Amyl nitrite (rapid acting) Nitroglycerin (both rapid and long acting Isosorbide dinitrate (both rapid and long acting) Isosorbide mononitrate (primarily long acting)
109
antianginal agent that are used to treat stable, unstable, and vasospastic (Prinzmetal) angina.
nitrates
110
Rapid-acting dosage forms of nitrates are most often
sublingual nitroglycerin tablets, or an intravenous drip
111
contraindication of nitrites and nitrates
severe anemia allergy to nitrates head trauma and cerebral hemorrhage pregnancy and lactation renal and hepatic disease
112
Nitrate antianginal drugs can produce additive hypotensive effects when taken in combination with
alcohol beta blockers calcium channel blockers, phenothiazines erectile dysfunction drugs
113
erectile dysfunction drugs examples
sildenafil (Viagra) , tadalafil, and vardenafil.
114
sildenafil should not be taken with erectile dysfunction drugs coz it will ___
cause dangerous drop in bp
115
Nitroglycerin is contraindicated in patients who have
severe anemia increased intracranial pressure hypersensitivity circulatory failure
116
these antianginals help by slowing the heart rate and decreasing contractility, thereby decreasing oxygen demands
beta blockers
117
beta blockers approved as antianginal drugs are
atenolol, metoprolol, nadolol, propranolol
118
these drugs are most effective in the treatment of exertional angina (i.e., that caused by exercise).
beta blockers
119
For an individual (often elderly) with significant angina, “exercise” may simply be carrying out the activities of daily living, such as
bathing dressing cooking housekeeping
120
The beta blockers are also approved for the treatment of
MI hypertension cardiac dysrhythmias essential tremor
121
these drugs decrease calcium influx into the smooth muscle, causing vascular relaxation. This either reverses or prevents the spasms of coronary vessels that cause the anginal pain associated with Prinzmetal or chronic angina.
calcium-channel blockers
122
There are three chemical classes of calcium channel blockers (CCBs)
phenylalkylamines, benzothiazepines, and dihydropyridines, commonly represented by verapamil, diltiazem, and amlodipine, respectively
123
these are considered first-line drugs for the treatment of such conditions as angina, hypertension, and supraventricular tachycardia
calcium-channel blockers
124
The dihydropyridine CCB nimodipine is indicated solely for
cerebral artery spasms associated with aneurysm rupture
125
CCBs are also used for the short-term management of
atrial fibrillation and flutter, migraine headaches, and Raynaud’s disease (a type of peripheral vascular disease)
126
contraindications of CCB
drug allergy acute MI second or third-degree AV block (unless the patient has a pacemaker) hypotension
127
Chest pain that occurs when the heart’s supply of blood carrying oxygen is insufficient to meet the demands of the heart
angina pectoris
128
A common form of arteriosclerosis involving deposits of fatty, cholesterol-containing material (plaques) within arterial walls
atherosclerosis
129
Chest pain that is primarily caused by atherosclerosis, which results in a long-term but relatively stable level of obstruction in one or more coronary arteries
chronic stable angina
130
Arteries that deliver oxygen to the heart muscle
coronary arteries
131
Any one of the abnormal conditions that can affect the arteries of the heart and produce various pathological effects, especially a reduced supply of oxygen and nutrients to the myocardium
coronary artery disease
132
Poor blood supply to an organ
ischemia
133
Poor blood supply to the heart via the coronary arteries
ischemic heart disease
134
Necrosis of the myocardium following interruption of blood supply; it is almost always caused by atherosclerosis of the coronary arteries and is commonly called a heart attack
Myocardial Infarction
135
A rapid heartbeat caused by a variety of autonomic nervous system effects, such as blood pressure changes, fever, or emotional stress.
reflex tachycardia
136
Early stage of progressive coronary artery disease.
unstable angina
137
induced myocardial chest pain caused by spasms of the coronary arteries; also referred to as Prinzmetal or variant angina.
vasospastic angina ischemia
138
these drugs lower serum levels of cholesterol and various lipids. These include bile acid sequestrants, HMG-CoA reductase inhibitors, and a cholesterol absorption inhibitor
lipid-lowering agents
139
subclasses of lipid lowering agents
bile acid sequestrants HMG-COA Reductase Inhibitors/ Statins cholesterol absorption inhibitors
140
these drugs prevent the reabsorption of bile salts, which are very high in cholesterol. Consequently, the liver will pull cholesterol from the blood to make new bile acids, lowering the serum cholesterol level.
bile acid sequestrants
141
drugs under bile acid sequestrants
● Cholestyramine (Questran) ● Colestipol (Colestid) ● Colesevelam (WelChol)
142
these drugs bind with bile acids in the intestine to form an insoluble complex that is then excreted in the feces.
bile acid sequestrants
143
these contain high levels of cholesterol.
bile acids
144
the liver use it to make more bile acids
cholesterol
145
This is used to treat pruritus associated with partial biliary obstruction.
Cholestyramine
146
Cholestyramine is a power that must be mixed with liquids and taken up to
6x a day
147
Colestipol is available in
powder and tablet form
148
Colestipol is taken only
4x a day
149
Colesevelam is available in
tablet form
150
Colesevelam is taken only
once or 2x a day
151
Bile Acid sequestrants are contraindicated in the presence of allergy to
any bile acid sequestrant
152
bile acid sequestrants also are contraindicated in the following conditions:
complete biliary obstruction abnormal intestinal function pregnancy or lactation
153
bile acid sequestrants decrease or delay the absorption of
thiazide diuretics digoxin warfarin thyroid hormones corticosteroids
154
Consequently, any of these drugs should be taken ____ after the bile acid sequestrant
1hour before or 4 to 6 hours
155
these drugs block the enzyme HMG-CoA reductase, resulting in lower serum cholesterol levels, a resultant breakdown of LDLs, and a slight increase in HDLs
HMG-CoA reductase inhibitors, or statins
156
Drug under HMG-COA Reductase inhibitors/ statins
● Artovastatin (Lipitor) ● Fluvastatin (Lescol) ● Lovastatin (Mevacor) ● Pravastatin (Pravachol) ● Rosuvastatin (Crestor) ● Simvastatin (Zocor)
157
The early rate-limiting step in the synthesis of cellular cholesterol involves the enzyme
HMG-COA reductase
158
if HMG-CoA reductase is blocked, what happens
serum cholesterol and LDL levels decrease because more LDLs are absorbed by the cells for processing into cholesterol
159
these enzymes block HMG-CoA reductase from completing the synthesis of cholesterol
HMG-CoA reductase inhibitor
160
(one of the oldest HMG-CoA drugs available
pravastatin lovastatin
161
are indicated for patients with documented CAD to slow progression of the disease
simvastatin
162
these statins are used to prevent a first myocardial infarction (MI) in patients who have multiple risk factors for developing CAD.
pravastatin lovastatin simvastatin atorvastatin
163
The peak effect of statin drugs is usually seen
within 2 to 4 weeks
164
a breakdown of muscles whose waste products can injure the glomerulus and cause acute renal failure, has also occurred with the use of all of these drugs
Rhabdomyolysis
165
The risk of rhabdomyolysis increases if any of statin drugs is combined with
erythromycin cyclosporine gemfibrozil niacin antifungal drugs
166
Serum levels and the risk of toxicity increase if statin drugs are combined with
grapefruit juice
167
works in the brush border of the small intestine to prevent the absorption of dietary cholesterol, which leads to increased clearance of cholesterol by the liver and a resultant fall in serum cholesterol.
cholesterol absorption inhibitor ezetimibe
168
these are very important parts of the overall treatment of a patient receiving a cholesterol absorption inhibitor
Change in diet and increased exercise
169
this drug works in the brush border of the small intestine to decrease the absorption of dietary cholesterol from the small intestine.
ezetimibe
170
Ezetimibe is absorbed well after oral administration, reaching peak levels in
4-6 hours
171
ezetimibe is metabolized in the liver and the small intestine, with a half-life of
22 hours
172
The risk of elevated serum levels of ezetimibe increases if it is given with
cholestyramine fenofibrate gemfibrozil antacids
173
ezetimibe should be taken at least___ before or ___ after the other drugs.
2 hours before 4 hours after
174
The risk of toxicity also increases if ezetimibe is combined with
cyclosporine
175
If ezetimibe is combined with any fibrate, the risk of ___ increases.
cholethiasis
176
___ levels increase in a patient who is also taking ezetimibe
warfarin
177
general term used for drugs used to lower lipid levels in the blood.
Antihyperlipidemic agents
178
cholesterol-containing acids found in the bile that act like detergents to break up fats in the small intestine
bile acids
179
necessary component of human cells that is produced and processed in the liver, then stored in the bile until stimulus causes the gallbladder to contract and send the bile into the duodenum via the common bile duct; a fat that is essential for the formation of steroid hormones and cell membranes; it is produced in cells and taken in by dietary sources
cholesterol
180
carrier for lipids in the bloodstream, consisting of proteins, lipids, cholesterol, and so forth.
chylomicron
181
endogenous substances that activate nervous system receptors that are important in the regulation of appetite, food intake, and metabolism.
Endocannabinoids
182
loosely packed chylomicron containing fats, able to absorb fats and fat remnants in the periphery; thought to have a protective effect, decreasing the development of coronary artery disease.
HDL
183
enzyme that regulates the last step in cellular cholesterol synthesis
HMG-CoA reductase
184
HMG-CoA reductase stands for
hydroxymethylglutaryl-coenzyme A reductase
185
increased levels of lipids in the serum, associated with increased risk of coronary artery disease development.
hyperlipidemia
186
tightly packed fats that are thought to contribute to the development of coronary artery disease when remnants left over from the LDL are processed in the arterial lining.
LDL
187
a collection of factors, including insulin resistance, abdominal obesity, low high-density lipoprotein and high triglyceride levels, hypertension, and proinflammatory and prothrombotic states, that increase the incidence of coronary artery disease
metabolic syndrome
188
factors that have been identified as increasing the risk of the development of a disease; for coronary artery disease, risk factors include genetic predisposition, gender, age, high-fat diet, sedentary lifestyle, gout, hypertension, diabetes, and estrogen deficiency
risk factors
189
subclasses of drugs affecting blood coagulation
anticoagulants antiplatelet drugs thrombolytic drugs
190
are drugs that interfere with the normal coagulation process by interfering with the clotting cascade and thrombin formation
anticoagulants
191
Drug under Anticoagulants
·antithrombin III (Thrombate III) ·argatroban (Acova) ·bivalirudin (Angiomax) ·desirudin (Iprivask) ·fondaparinux (Arixtra) ·heparin (generic) · warfarin (Coumadin)
192
these drugs interfere with the normal cascade of events involved in the clotting process
anticoagulants
193
these block the formation of thrombin from prothrombin
Heparin, argatroban, and bivalirudin
194
Adverse effects of anticoagulants can range from
bleeding gums with tooth brushing to severe internal hemorrhage
195
Warfarin has been associated with
alopecia dermatitis bone marrow depression
196
what happens if heparin is combined with oral anticoagulants, salicylates, penicillins, or cephalosporins
increased bleeding
197
this can occur if heparin is combined with nitroglycerin
decreased anticoagulation
198
To treat heparin drug overdose,
protamine sulfate
199
used to treat warfarin overdose
Vitamin K
200
this drug decrease the formation of the platelet plug by decreasing the responsiveness of the platelets to stimuli that would cause them to stick and aggregate on a vessel wall
antiplatelet agents
201
Drug under anticoagulant
·abciximab (ReoPro) ·anagrelide (Agrylin) ·aspirin ·cilostazol (Pletal) ·clopidogrel (Plavix) ·dipyridamole (Persantine) ·eptifibatide (Integrilin) ·sulfinpyrazone (Anturane) ·ticlopidine (Ticlid) ·tirofiban (Aggrastat).
202
this inhibit platelet adhesion and aggregation by blocking receptor sites on the platelet membrane, preventing platelet–platelet interaction or the interaction of platelets with other clotting chemicals.
antiplatelet agents
203
One drug ___ blocks the production of platelets in the bone marrow.
anagrelide
204
These agents are used effectively to treat cardiovascular diseases that are prone to produce occluded vessels; for the maintenance of venous and arterial grafts; to prevent cerebrovascular occlusion; and as adjuncts to thrombolytic therapy in the treatment of myocardial infarction (MI) and the prevention of reinfarction after MI. T
antiplatelet
205
these drugs break down the thrombus that has been formed by stimulating the plasmin system
thrombolytic agents
206
drugs under thrombolytic agents
·alteplase (Activase) ·reteplase (Retavase) ·streptokinase (Streptase) ·tenecteplase (TNKase) ·urokinase (Abbokinase)
207
All of the drugs that are available for this purpose work to activate the natural anticlotting system—conversion of plasminogen to ___
plasmin
208
The thrombolytics are effective only if the patient has ___ in the plasma
plasminogen
209
The most common adverse effect associated with the use of thrombolytic agents is
bleeding
210
The risk of hemorrhage increases if thrombolytic agents are used with
any anticoagulant or antiplatelet drug
211
Arrange to administer ___ to reduce mortality associated with acute MI as soon as possible after the onset of symptoms
tenecteplase or streptokinase
212
what to do with heparin if it is being given administration of a thrombolytic agent
discontinue
213
drugs that block or inhibit any step of the coagulation process, preventing or slowing clot formation
anticoagulants
214
drugs that interfere with the aggregation or clumping of platelets to form the platelet plug
antiplatelet agents
215
the process of blood’s changing from a fluid state to a solid state to plug injuries to the vascular system
coagulation
216
drugs that lyse, or break down, a clot that has formed; these drugs activate the plasminogen mechanism to dissolve fibrin threads
thrombolytic agents
217
drugs used to treat anemia subclasses
erythropoiesis stimulating agents agents used for iron-deficiency anemia agents used for other anemias
218
A substance that stimulates the bone marrow to make more red blood cells
erythropoiesis stimulating agents
219
are used to treat anemia caused by chronic kidney failure, some anticancer drugs, and certain treatments for HIV. They may also be used to lower the number of blood transfusions needed during and after certain major surgeries
erythropoiesis stimulating agents
220
drugs under erythropoiesis stimulating agents
● Darbepoetin alfa ● Epoetin alfa ● Methoxy polyethylene glycol-epoetin beta
221
Is a man-made form of a protein that helps your body produce red blood-cells. It is used to treat anemia caused by chemotherapy or chronic kidney disease.
Darbepoetin alfa (Aranesp)
222
This medicine is used to treat anemia associated with renal failure and patients on dialysis; reduction in need for transfusions in surgical patients; treatment of anemia associated with AIDS therapy; treatment of anemia associated with cancer chemotherapy
Epoetin alfa (Epogen)-
223
Used to treat anemia associated with chronic renal failure, including in dialysis patients
Methoxy polyethylene glycol-epoetin beta (Mircera)
224
Generally indicated in conditions where there is
impaired red blood cell production
225
The two primary FDA approved indications for ESAs are
anemia secondary to chronic kidney disease chemotherapy-induced anemia in patients with cancer
226
All ESA drugs are contraindicated in the presence of
uncontrolled hypertension
227
drugs under agents used for iron-deficiency anemia
● Ferrous fumarate (Feostat) ● Ferrous gluconate (Fergon) ● Ferrous sulfate (Feosol) ● Ferrous sulfate exsiccated (Feratab, Slow FE) ● Iron dextran (InFeD)
228
Treatment of iron deficiency in patients undergoing chronic hemodialysis or nondialysis patients with renal failure who are also receiving supplemental erythropoietin therapy
Iron sucrose (Venofer)
229
Treatment of iron deficiency in patients undergoing chronic hemodialysis who are also receiving supplemental erythropoietin therapy
Sodium ferric gluconate complex (Ferrlecit)
230
agents used for iron-deficiency anemia may also be used as adjunctive therapy in patients receiving an
erythropoiesis-stimulating drug
231
is a parenteral form of iron given by the Z-track method
Iron dextran
232
agents used for iron-deficiency anemia that are available for oral administration
Ferrous fumarate ferrous gluconate ferrous sulfate
233
agents used for iron-deficiency anemia are contraindicated in the following conditions
hemochromatosis (excessive iron) hemolytic anemias normal iron balance peptic ulcer colitis regional enteritis
234
Iron absorption decreases if iron preparations are taken with
antacids, tetracyclines, or cimetidine
235
Increased iron levels occur if iron preparations are taken with
chloramphenicol
236
AGENTS FOR MEGALOBLASTIC ANEMIAS
1. Folic Acid Derivatives 2. Vitamin B12
237
AGENT FOR SICKLE CELL ANEMIA
Hydroxyurea
238
a synthetic form of folate, a B vitamin, used to treat or prevent low folate levels, which can lead to certain types of anemia or birth defects.
Folic acid (Folvite)
239
used as “leucovorin rescue” after chemotherapy, allowing non cancerous cells to survive the chemotherapy; used with fluorouracil for palliative treatment of colorectal cancer
Leucovorin (Wellcovorin)
240
Folic Acid Derivatives
Folic acid (Folvite) Leucovorin (Wellcovorin) Levoleucovorin
241
used in adults and children to prevent harmful effects of methotrexate (Trexall) when methotrexate is used to treat osteosarcoma (cancer that forms in bones)
Levoleucovorin
242
a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin.
Cyanocobalamin (Nascobal)
243
a manufactured version of the vitamin B12. It is used to treat and prevent vitamin B12 deficiency anemia
Hydroxocobalamin (Hydro-Crysti-12)
244
Vitamin B12 drugs
Cyanocobalamin (Nascobal) Hydroxocobalamin (Hydro-Crysti-12)
245
Megaloblastic anemia is treated with folic acid and vitamin B12 tissue.
folic acid and vitamin B12 tissue.
246
Vitamin B12 is also necessary for maintenance of the
myelin sheat in nerve tissue
247
Folate deficiency may result from increased loss of
folate
248
False low serum and red cell folate levels may occur if the patient has been taking antibiotics, such as tetracycline, which suppress the growth of
Lactobacillus casei
249
a cytotoxic antineoplastic drug that is also used to treat leukemia, ovarian cancer and melanoma. It interferes with the growth of cancer cells, which are eventually destroyed by the body.
Hydroxyurea
250
Reduction of frequency of painful crisis and need for blood transfusions in adult patients with
sickle cell anemia
251
used to treat sickle cell anemia
hydroxyurea
252
hydroxyurea has a half life of
3-4 hours
253
hydroxyurea has a peak levels of
1-4 hours
254
disorder involving too few red blood cells (RBCs) or ineffective RBCs that can alter the blood’s ability to carry oxygen
anemia
255
RBCs, responsible for carrying oxygen to the tissues and removing carbon dioxide; they have no nucleus and live approximately 120 days
erythrocytes
256
process of RBC production and life cycle; formed by megaloblastic cells in the bone marrow, using iron, folic acid, carbohydrates, vitamin B12, and amino acids; they circulate in the vascular system for about 120 days and then are lysed and recycled
erythropoiesis
257
glycoprotein produced by the kidneys, released in response to decreased blood flow or oxygen tension in the kidney; controls the rate of RBC production in the bone marrow
erythropoietin
258
low RBC count with low iron available because of high demand, poor diet, or poor absorption; treated with iron replacement
iron-deficiency anemia
259
anemia caused by lack of vitamin B12 and/or folic acid, in which RBCs are fewer in number and have a weak stroma and a short lifespan; treated by replacement of folic acid and vitamin B12
megaloblastic anemia